Injectafer denied for missing prior authorization by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for injectafer are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Requires Prior Authorization for Injectafer — and How to Secure Approval

Injectafer (ferric carboxymaltose) is a specialty infusion product that BlueCross BlueShield routinely places on prior-authorization (PA) review. A prior-auth-required denial — meaning the drug was administered or requested without an approved PA, or the PA request was denied after review — is one of the most common and most winnable denial types for IV iron therapy. The prior authorization process exists as an administrative gatekeeping step; it does not reflect a judgment that the drug is never appropriate, only that BCBS requires upfront clinical documentation before approving access.

## Why This Denial Is Appealable

If PA was denied after submission, the denial letter must state the specific clinical criteria that were not met. You have the right under ERISA §503 and ACA §2719 to a full-and-fair review of that determination. The appeal process allows your prescribing physician to submit additional or clarifying documentation that directly addresses each unmet criterion. PA denials are overturned at a high rate when the appeal package directly maps clinical chart evidence to each criterion in the insurer's coverage policy. If PA was never submitted (i.e., the drug was given without prior authorization), the appeal focuses on retroactive authorization using the same clinical documentation.

## Federal Appeal Framework

• Internal appeal: File under ACA §2719 or ERISA §503. The plan must disclose the specific criteria applied and all documents relied upon in the PA denial determination.
• Concurrent review / retroactive authorization: If applicable, request retroactive PA authorization simultaneously with the internal appeal.
• External review: Escalate to an IRO within the approximately four-month window from final internal denial.
• Expedited review: If the patient needs ongoing infusions imminently, request expedited review at every stage — decisions can come within 72 hours (standard) or 24–72 hours (expedited) depending on plan rules.

## Concrete Appeal Steps and Timeline

1. Obtain the denial letter and identify each specific PA criterion that BCBS states was not met. 2. Consult the BCBS prior-authorization coverage policy for Injectafer to see all required criteria. 3. Assemble documentation that directly addresses each unmet criterion (see below). 4. Submit the internal appeal with a prescriber letter by the deadline on the denial notice. 5. If denied, file for external IRO review immediately.

## Documentation to Gather

• Diagnosis confirmation: Lab results and physician notes confirming iron-deficiency anemia and its underlying etiology (e.g., chronic kidney disease, inflammatory bowel disease, post-surgical malabsorption, heavy uterine bleeding).
• Prior oral iron trial: Documented dates, duration, formulations, and outcomes — including intolerance, adverse effects, or failure to achieve repletion — demonstrating why oral iron is not appropriate.
• Clinical severity: Notes documenting hemoglobin trend, symptom burden, comorbidities that elevate urgency, and the clinical rationale for IV rather than oral repletion.
• Prescriber medical-necessity letter: A letter explicitly addressing each BCBS PA criterion, confirming that all requirements are met, and citing the applicable clinical guideline organization's recommendations.

## Criteria-Mapping Structure

Obtain BCBS's PA coverage policy for Injectafer. In your appeal, create a section for each criterion: state the criterion verbatim, then provide the specific chart entry, lab value date, or physician statement that satisfies it. This structured, criterion-by-criterion format is the single most effective approach to converting a PA denial into an approval on appeal.